Effectiveness of the Single Implant-retained Mandibular Overdenture Treatment
Launched by UNIVERSIDADE FEDERAL DE GOIAS · Feb 28, 2013
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
This study is a longitudinal evaluation of clinical and patient-reported outcomes related to the single-implant mandibular overdenture treatment. Sixty completely edentulous individuals will be included. First, new complete dentures will be fabricated for all of them. Panoramic radiographs and conventional tomograms of the mandibular midline region will be obtained in order to plan the implant placement surgery. After the adaptation period related to the use of the new dentures, a single implant (Titamax IT Cortical, Neodent, Curitiba, Brazil) will be installed in the mandibular midline of ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Fully edentulous patients
- • Need of replacement of the mandibular denture or patient without mandibular denture
- • Patients with poor adaptation to the mandibular denture
- • Patients with good general health
- Exclusion Criteria:
- • Patients who refuse to receive a conventional dentures opposed to a mandibular overdenture retained by a single implant
- • Patients with local intraoral diseases that influence denture stability, retention and adaptation of the lower denture (such as changes or anatomical deformations of the jaws, mucosal changes caused by fungi and bacteria, tumor changes and absolute xerostomia)
- • Patients with systemic, psychological or neurological diseases that preclude or hinder oral movements of the patient for clinical care and/or clinical follow-up in all stages of the research
- • Patients who choose other treatment modalities not covered by the study
- • Patients with alcoholism or other severe behavioral disorders that compromise their participation in the study
About Universidade Federal De Goias
The Universidade Federal de Goiás (UFG) is a prominent Brazilian higher education institution renowned for its commitment to advancing research and healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, UFG aims to enhance medical knowledge and improve patient outcomes by conducting rigorous, ethical studies across various therapeutic areas. The university fosters a research environment that combines academic excellence with community engagement, ensuring that its clinical trials not only contribute to scientific advancement but also address pressing health challenges faced by diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Goiania, Goias, Brazil
Patients applied
Trial Officials
Claudio R Leles, DDS, PhD
Principal Investigator
Universidade Federal de Goias
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials